BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22901184)

  • 1. PBK/TOPK expression during TPA-induced HL-60 leukemic cell differentiation.
    Liu YH; Gao XM; Ge FM; Wang Z; Wang WQ; Li XY
    Asian Pac J Cancer Prev; 2012; 13(5):2145-8. PubMed ID: 22901184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein expression of PDZ-binding kinase is up-regulated in hematologic malignancies and strongly down-regulated during terminal differentiation of HL-60 leukemic cells.
    Nandi A; Tidwell M; Karp J; Rapoport AP
    Blood Cells Mol Dis; 2004; 32(1):240-5. PubMed ID: 14757441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PBK/TOPK mediates promyelocyte proliferation via Nrf2-regulated cell cycle progression and apoptosis.
    Liu Y; Liu H; Cao H; Song B; Zhang W; Zhang W
    Oncol Rep; 2015 Dec; 34(6):3288-96. PubMed ID: 26503118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitotic kinase PBK/TOPK as a therapeutic target for adult T‑cell leukemia/lymphoma.
    Ishikawa C; Senba M; Mori N
    Int J Oncol; 2018 Aug; 53(2):801-814. PubMed ID: 29901068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PBK/TOPK expression correlates with mutant p53 and affects patients' prognosis and cell proliferation and viability in lung adenocarcinoma.
    Lei B; Qi W; Zhao Y; Li Y; Liu S; Xu X; Zhi C; Wan L; Shen H
    Hum Pathol; 2015 Feb; 46(2):217-24. PubMed ID: 25466965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative proteomics analysis on differentiation of human promyelocytic leukemia HL-60 cells into granulocyte and monocyte lineages.
    Wang WJ; Tang W; Qiu ZY
    Ai Zheng; 2009 Feb; 28(2):117-21. PubMed ID: 19550115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
    Miranda MB; McGuire TF; Johnson DE
    Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [EGR-1 mRNA expression during 12-0-tetradecanoylphorbol-13-acetate-induced K562 cell differentiation].
    Fang DZ; Liao QK; Gao J; Yang XJ; Yuan LX; Jia GC
    Zhonghua Er Ke Za Zhi; 2004 Jul; 42(7):495-8. PubMed ID: 15324564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21.
    Hu F; Gartenhaus RB; Eichberg D; Liu Z; Fang HB; Rapoport AP
    Oncogene; 2010 Oct; 29(40):5464-74. PubMed ID: 20622899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carnosic acid and promotion of monocytic differentiation of HL60-G cells initiated by other agents.
    Danilenko M; Wang X; Studzinski GP
    J Natl Cancer Inst; 2001 Aug; 93(16):1224-33. PubMed ID: 11504768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute promyelocytic leukemia mutated to radioresistance suppressed monocyte lineage differentiation by phorbol 12-myristate 13-acetate.
    Monzen S; Takimura K; Kashiwakura I; Hosokawa Y
    Leuk Res; 2013 Sep; 37(9):1162-9. PubMed ID: 23773897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic, nuclear, and total PBK/TOPK expression is associated with prognosis in colorectal cancer patients: A retrospective analysis based on immunohistochemistry stain of tissue microarrays.
    Su TC; Chen CY; Tsai WC; Hsu HT; Yen HH; Sung WW; Chen CJ
    PLoS One; 2018; 13(10):e0204866. PubMed ID: 30286126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PBK/TOPK in the differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma and its involvement in prognosis of human cholangiocarcinoma.
    He F; Yan Q; Fan L; Liu Y; Cui J; Wang J; Wang L; Wang Y; Wang Z; Guo Y; Huang G
    Hum Pathol; 2010 Mar; 41(3):415-24. PubMed ID: 19954816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gossypetin Inhibits Solar-UV Induced Cutaneous Basal Cell Carcinoma Through Direct Inhibiting PBK/TOPK Protein Kinase.
    Wang L; Zhang Z; Ge R; Zhang J; Liu W; Mou K; Lv S; Mu X
    Anticancer Agents Med Chem; 2019; 19(8):1029-1036. PubMed ID: 30827262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PBK/TOPK, a proliferating neural progenitor-specific mitogen-activated protein kinase kinase.
    Dougherty JD; Garcia AD; Nakano I; Livingstone M; Norris B; Polakiewicz R; Wexler EM; Sofroniew MV; Kornblum HI; Geschwind DH
    J Neurosci; 2005 Nov; 25(46):10773-85. PubMed ID: 16291951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of p21Cip1 or p27Kip1 in the promyelocytic leukemia cell line HL60 accelerates its lineage-specific differentiation.
    Zhou P; Yao Y; Soh JW; Weinstein IB
    Anticancer Res; 1999; 19(6B):4935-45. PubMed ID: 10697493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protein kinase C beta-specific inhibitor LY379196 blocks TPA-induced monocytic differentiation of HL60 cells the protein kinase C beta-specific inhibitor LY379196 blocks TPA-induced monocytic differentiation of HL60 cells.
    Slosberg ED; Yao Y; Xing F; Ikui A; Jirousek MR; Weinstein IB
    Mol Carcinog; 2000 Mar; 27(3):166-76. PubMed ID: 10708478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of PBK/TOPK Contributes to Tumor Development and Poor Outcome of Esophageal Squamous Cell Carcinoma.
    Ohashi T; Komatsu S; Ichikawa D; Miyamae M; Okajima W; Imamura T; Kiuchi J; Nishibeppu K; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Anticancer Res; 2016 Dec; 36(12):6457-6466. PubMed ID: 27919968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial targeting of JNK/SAPK in the phorbol ester response of myeloid leukemia cells.
    Ito Y; Mishra NC; Yoshida K; Kharbanda S; Saxena S; Kufe D
    Cell Death Differ; 2001 Aug; 8(8):794-800. PubMed ID: 11526432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the 67-kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation.
    Montuori N; Selleri C; Risitano AM; Raiola AM; Ragno P; Del Vecchio L; Rotoli B; Rossi G
    Clin Cancer Res; 1999 Jun; 5(6):1465-72. PubMed ID: 10389934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.